drug
adrenaline
Marketedupdated 3mo agoby International Medication Systems Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE540 co-mentions · 153 sources
- drugEPINEPHRINE455 co-mentions · 153 sources
- drugEPIPEN E Z PEN455 co-mentions · 153 sources
- tagApproval434 co-mentions · 141 sources
- drugepinephrine Fresenius390 co-mentions · 153 sources
- drugLIDOCAINE163 co-mentions · 81 sources
- druglidocaine SR163 co-mentions · 81 sources
- drugLIDOCAINE HYDROCHLORIDE153 co-mentions · 77 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 19 approved and 33 investigational indications.
all catalysts(100)
approval · 100
Sep 13, 1985
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 7, 1987
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 22, 1987
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 21, 1988
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 21, 1988
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 21, 1988
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 21, 1988
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 21, 1988
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 2, 1989
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
May 10, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 6, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 6, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 6, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 6, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 6, 1989
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 21, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 21, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 21, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 21, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 21, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 9, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 9, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 9, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 9, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 9, 1990
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Feb 15, 1991
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Aug 3, 1995
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Oct 23, 1995
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 25, 1996
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 24, 1997
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 1997
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 1997
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 1997
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 1997
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 1997
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 26, 1998
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
May 25, 1999
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 5, 1999
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 15, 1999
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
May 11, 2000
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 11, 2001
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Aug 27, 2001
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 2, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Feb 20, 2002
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 16, 2002
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 28, 2002
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Aug 21, 2002
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 3, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 3, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 11, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 16, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 19, 2002
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 27, 2002
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 17, 2003
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 26, 2008
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
May 19, 2009
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 9, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 12, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 12, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 12, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 12, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 15, 2010
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Aug 20, 2012
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 23, 2013
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Sep 16, 2013
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Nov 8, 2013
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Dec 13, 2013
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 30, 2014
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 17, 2014
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Mar 3, 2016
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
May 18, 2016
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Apr 28, 2017
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Aug 23, 2018
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jan 31, 2020
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jun 17, 2020
approval
$VTRS16.280.00%
EPIPEN E Z PEN (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Jul 15, 2020
approval
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approval
adrenaline
→
Trials studying adrenaline
- phase3Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- phase4Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
- phase1PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
- phase2Phase 2B Upper Extremity Nerve Block Study
- phase4Epinephrine Dose: Optimal Versus Standard Evaluation Trial
- phase2Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
- phase2An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
- phase2Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 12, 2026
122 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (71)
- Jan 17, 2045formulationUS 12539283
- Mar 21, 2039formulationUS 10653646
- Mar 21, 2039formulationUS 10653646
- Mar 21, 2039formulationUS 10653646
- Mar 21, 2039formulationUS 10653646
- Mar 21, 2039formulationUS 10653646
- Mar 21, 2039method-of-use (U-3567)US 11083698
- Mar 21, 2039method-of-use (U-3567)US 11083698
- Mar 21, 2039method-of-use (U-3567)US 11083698
- Mar 21, 2039method-of-use (U-3567)US 11083698
- Mar 21, 2039method-of-use (U-3567)US 11083698
- Mar 21, 2039formulationUS 11207280
- Mar 21, 2039formulationUS 11207280
- Mar 21, 2039formulationUS 11207280
- Mar 21, 2039formulationUS 11207280
- Mar 21, 2039formulationUS 11207280
- Mar 21, 2039formulationUS 12133837
- Mar 21, 2039formulationUS 12133837
- Mar 21, 2039formulationUS 12133837
- Mar 21, 2039formulationUS 12133837
- Mar 21, 2039formulationUS 12133837
- Feb 6, 2039method-of-use (U-3979)US 10682414
- Feb 6, 2039method-of-use (U-3979)US 10682414
- Feb 6, 2039formulationUS 11191838
- Feb 6, 2039formulationUS 11191838
- Feb 6, 2039method-of-use (U-3979)US 11717571
- Feb 6, 2039method-of-use (U-3979)US 11717571
- Feb 6, 2039method-of-use (U-3979)US 11744895
- Feb 6, 2039method-of-use (U-3979)US 11744895
- Feb 6, 2039formulationUS 11918655
- Feb 6, 2039method-of-use (U-3979)US 11918655
- Feb 6, 2039formulationUS 12324838
- Feb 6, 2039formulationUS 12324838
- Feb 6, 2038formulationUS 10576156
- Feb 6, 2038formulationUS 10576156
- Feb 6, 2038method-of-use (U-3979)US 11173209
- Feb 6, 2038method-of-use (U-3979)US 11173209
- Dec 21, 2037formulationUS 10688244
- Dec 21, 2037formulationUS 10688244
- Dec 21, 2037formulationUS 10842938
- Dec 21, 2037formulationUS 10842938
- Dec 21, 2037formulationUS 11771830
- Dec 21, 2037formulationUS 11771830
- Oct 20, 2036formulationUS 11141540
- Oct 20, 2036formulationUS 11141540
- Mar 13, 2035formulationUS 10130592
- Mar 13, 2035formulationUS 12280024
- Mar 13, 2035formulationUS 12280024
- Mar 13, 2035formulationUS 9119876
- Mar 13, 2035formulationUS 9119876
- Mar 13, 2035method-of-use (U-1829)US 9295657
- Mar 13, 2035method-of-use (U-1829)US 9295657
- Nov 2, 2029formulationUS 80213443.2y
- Nov 2, 2029formulationUS 80213443.2y
- Nov 2, 2029formulationUS 80213443.2y
- Apr 10, 2029formulationUS 82266102.7y
- Apr 10, 2029formulationUS 82266102.7y
- Apr 10, 2029formulationUS 82266102.7y
- Nov 25, 2028formulationUS 82315732.3y
- Nov 25, 2028formulationUS 82315732.3y
- Nov 25, 2028formulationUS 82315732.3y
- Mar 12, 2028formulationUS 79470171.6y
- Mar 12, 2028formulationUS 79470171.6y
- Mar 12, 2028formulationUS 79470171.6y
- Feb 27, 2027formulationUS 8206360199d
- Feb 27, 2027formulationUS 8206360199d
- Feb 27, 2027formulationUS 8206360199d
- Dec 12, 2026formulationUS 11590286122d
- Dec 12, 2026formulationUS 11590286122d
- Dec 12, 2026formulationUS 11590286122d
- Jan 26, 2026formulationUS 8367734
News(1)
- Chutes & Ladders—Legend CEO departs without successor in placeLegend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from CFO to CEO in 2020 after a Chinese customs investigation was opened on f…fiercebiotech · 12d ago
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that